Trials / Completed
CompletedNCT05100602
Clinical Evaluation of Genetron TERT PCR Kit in Glioma Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,192 (actual)
- Sponsor
- Genetron Health · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this trail is to evaluate the performance of Genetron TERT PCR Kit in Glioma patients using real-time PCR method.
Detailed description
This trial follows the principle of synchronous blinding. The enrolled cases are coded, and the enrolled samples are detected with the Genetron TERT PCR Kit and Sanger sequencing method. The results were determined independently according to the cutoff values or interpretation requirements provided by each method.Combined with the results of clinicopathological classification, the incidence of C228T and C250T mutations of TERT promoter genes in different subtypes was counted to evaluate the clinical application performance of the Genetron TERT PCR Kit.
Conditions
Timeline
- Start date
- 2016-05-13
- Primary completion
- 2016-09-22
- Completion
- 2016-12-08
- First posted
- 2021-10-29
- Last updated
- 2021-11-22
Locations
4 sites across 1 country: China
Source: ClinicalTrials.gov record NCT05100602. Inclusion in this directory is not an endorsement.